The Claim
Creatine supplementation may slow the progression of Alzheimer’s disease by up to 30 percent.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
Creatine supplementation is associated with a reduction in the rate of cognitive decline in Alzheimer’s disease by up to 30 percent.
See the scientific wording
Creatine supplementation may slow the progression of Alzheimer’s disease by up to 30 percent.
Taking creatine raises levels of a molecule in the brain that helps cells quickly make more energy. This extra energy lets brain cells work better, especially when they need to communicate or maintain their function, which helps memory and thinking stay sharper.
What the research says
2 studiesStudy: Creatine monohydrate pilot in Alzheimer's: Feasibility, brain creatine, and cognition
This small study found that Alzheimer’s patients who took creatine supplements for two months got a little better at remembering things and reading words. It doesn’t prove it stops the disease by 30%, but it does show creatine might help the brain work a bit better.
Study: Bioenergetic data from a creatine monohydrate pilot trial in Alzheimer's disease
This study found that taking creatine helped brain cells make more energy in people with Alzheimer’s, which might help slow how fast their memory gets worse. But it didn’t measure memory directly, so we can’t say for sure it cuts decline by 30%.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 2 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.